Arecor Therapeutics plc (FRA:6UI)
Germany · Delayed Price · Currency is EUR 0.8250
+0.0400 (5.10%)
At close: Jan 2, 2026
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of €37.42 million as of January 9, 2026. Its market cap has increased by 18.12% in one year.
Market Cap
37.42M
Enterprise Value
35.45M
Revenue
5.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.83
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 77.94M to 37.42M, a decrease of -51.99%. That is a compound annual growth rate of -14.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 37.42M | 7.41% |
| Dec 31, 2025 | 34.84M | 3.82% |
| Dec 31, 2024 | 33.56M | -47.90% |
| Dec 29, 2023 | 64.41M | -22.25% |
| Dec 30, 2022 | 82.85M | -37.50% |
| Dec 31, 2021 | 132.56M | 70.08% |
| Jun 3, 2021 | 77.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |